EIN 46-3481092

San Diego Biomedical Research Institute

IRS 501(c) type
Num. employees
Year formed
Most recent tax filings
The mission of SDBRI is to conduct fundamental biomedical research to better understand human disease and to use this information to contribute to the treatment and prevention of diabetes, cancer, HIV/AIDS, and complications of chronic disease. The mi...
Total revenues
Total expenses
Total assets
Num. employees

Program areas at San Diego Biomedical Research Institute

HIV/AIDS: The World Health Organization recently estimated that 36.7 million people live with HIV/AIDS worldwide with 1 million HIV-related deaths every year. New infections are estimated at an alarming 1.8 million worldwide. Developing a successful HIV vaccine is a major global health initiative. Research at SDBRI is focused on introducing novel designs to create an HIV vaccine that increases the frequency of recipients who respond successfully to the vaccine. The new SDBRI strategy of using HIV virus-like particles (VLPs) as a vaccine platform is showing great promise. In addition, over the past two years SDBRI scientists have identified pieces of the immune system that do not respond to HIV vaccines. This is very important because it allows us to identify those pieces of the immune system that are missing in some people. SDBRI continues to participate in a multi-organization HIV vaccine research program. Our investigators work with scientists across the U.S. and in several foreign countries, including The Netherlands and China. A Staff Scientist from China received salary & benefits while being trained at SDBRI in a variety of cellular, molecular and biochemical techniques to better understand the human response to vaccines.
HIV-associated neurological disease: Currently, more than half of HIV patients have HIV-associated neurocognitive disorder (HAND). Although drugs to control HIV infection have been instrumental in preventing progression to AIDS, they do not protect from HAND, which is now on the rise as this patient population is aging. SDBRI scientists working on HAND have discovered a biological process that we believe is involved in accelerating the aging process in people with HIV, increasing their risk of dementia. SDBRI scientists are now focused on designing and testing strategies to stop that biological process for the purpose of preventing the onset of dementia. In addition, drug abuse, particularly methamphetamine, increases the number of cells that HIV likes to infect in the central nervous system, increasing the HIV reservoir and aggravating inflammation. SDBRI research is focused on how methamphetamine encourages cells in the brain to attract and provide a home for HIV infection. This information will then be used to design therapies to stop HIV from infecting cells in the brain. A student from Austria received salary while being trained at SDBRI in a variety of cellular immunology and sterile techniques to better understand the effect of methamphetamine on HIV infection in experimental models.
Cancer & Muscle Health:Metastatic cancer is cancer that has spread from the site where it was first detected to another organ. Scientists at SDBRI are working on understanding how cancer cells move from one place to another so that we can develop new medicines that stop them from moving. Scientists at SDBRI have discovered a gene that, if left uncontrolled, can turn a normal cell into a cancer cell. This gene is present in very high amounts in cancer cells from women with the most aggressive form of breast cancer. SDBRI scientists have also identified molecules inside cancer cells that tell the cancer to move from one place to another. In experimental systems blocking the function of this gene and these molecules stops the cancer from spreading. That information is now being used to develop drugs to prevent the spread of cancer to other organs.Cachexia, pronounced kuh-kek-see-uh, is the profound loss of muscle that is often seen in people with late stage cancer. It is incredibly debilitating and is associated with poor response to medications and poor prognosis. So far, no single drug has successfully reversed or stopped cachexia. The goal of the SDBRI cachexia research team is to identify the problems that cause cachexia at a very early stage, before cachexia begins. Over the past several years research at SDBRI has identified immune cell types in the blood of cancer patients that are present at higher levels in patients with stronger and larger muscles than in patients with smaller and weaker muscles. The focus now is to find out whether these immune cells can be used as markers to predict which patients will become cachexic and whether increasing the number of these cells might prevent the onset of cachexia in those patients. SDBRI scientists work with scientists across the U.S. and India. This work involves the transfer of scientific information and training. A postdoctoral fellow from India received salary & benefits while being trained at SDBRI in cellular, molecular and biochemical techniques to understand how the immune system changes as the disease progresses, and how we can intervene to stop the devastating effects of cancer progression.

Who funds San Diego Biomedical Research Institute

Grants from foundations and other nonprofits
Medical Research Charities (MRC)To Assist in the Organization's Exempt Purposes.$19,043

Personnel at San Diego Biomedical Research Institute

Joanna Davies , Ph.D.President$240,906
Sheila FergusonTreasurer$0
Jeff Steindorf , Ph.D.Director and Chairman$0
Barbara LambSecretary$0
Cary E. ThomasChairman$0

Financials for San Diego Biomedical Research Institute

RevenuesFYE 06/2020
Total grants, contributions, etc.$5,241,067
Program services$0
Investment income and dividends$0
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$47,994
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$5,289,061

Form 990s for San Diego Biomedical Research Institute

Fiscal year endingDate received by IRSFormPDF link
2020-062021-05-20990View PDF
2019-062021-01-21990View PDF
2018-062019-06-19990View PDF
2017-062018-09-12990View PDF
2016-062017-08-31990View PDF
...and 2 more Form 990s
Data update history
June 2, 2022
Received grants
Identified 1 new grant, including a grant for $19,043 from Medical Research Charities (MRC)
May 20, 2022
Used new vendors
Identified 2 new vendors, including , and
August 23, 2021
Posted financials
Added Form 990 for fiscal year 2020
August 21, 2021
Posted financials
Added Form 990 for fiscal year 2019
March 3, 2021
Updated personnel
Identified 1 new personnel
Nonprofit Types
Medical research organizationsResearch centersCharities
Science and technologyHealthDiseases and disordersCancerHIV / AIDS
Conducts researchState / local levelReceives government fundingTax deductible donations
General information
10865 Rd To the Cure
San Diego, CA 92121
Metro area
San Diego-Chula Vista-Carlsbad, CA
San Diego County, CA
Website URL
(858) 200-7156
IRS details
Fiscal year end
Taxreturn type
Form 990
Year formed
Eligible to receive tax-deductible contributions (Pub 78)
NTEE code, primary
H90: Medical Specialty Research
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Free account sign-up

Want updates when San Diego Biomedical Research Institute has new information, or want to find more organizations like San Diego Biomedical Research Institute?

Create free Cause IQ account